SOVALDI (Sofosbuvir)
Published • Aug 30, 2017
NobleIDNI9P10W28R09S92
Authors:,
David Schlossberg
Rafik Samuel
Abstract
This chapter provides basic characteristics, FDA-approved indications, side effects/toxicity, dosage information, drug/food interactions and antimicrobial therapy art of SOVALDI (sofosbuvir). Sofosbuvir undergoes intracellular metabolism to form the pharmacologically active uridine analog triphospha...
Subject
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!